Data Collective IV GP, LLC
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1664974
PALO ALTO, CA
Position in RXRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$18,239,238
-$6,059,942 QoQ
Shares Held
5,941,120
0.0% QoQ
Ownership
1.12%
of shares outstanding
% of Portfolio
32.60%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Data Collective IV GP, LLC holds $20,135,853 across 2 Biotechnology names. RXRX ranks #1 (90.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RXRX |
Recursion Pharmaceuticals, Inc.
This page
|
5,941,120 | $18,239,238 | |
| 2 | DFTX |
Definium Therapeutics, Inc.
|
100,350 | $1,896,615 |
All Filings in RXRX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,239,238 | 5,941,120 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $24,299,180 | 5,941,120 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $28,992,665 | 5,941,120 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $30,062,067 | 5,941,120 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $31,428,524 | 5,941,120 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $40,161,971 | 5,941,120 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $39,151,980 | 5,941,120 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $44,558,400 | 5,941,120 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $59,232,966 | 5,941,120 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $58,579,443 | 5,941,120 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $45,449,568 | 5,941,120 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $44,380,166 | 5,941,120 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $39,627,270 | 5,941,120 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $45,806,035 | 5,941,120 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $63,213,516 | 5,941,120 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $48,360,716 | 5,941,120 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $42,538,419 | 5,941,120 | Shares | Sole | 2022-11-14 | |
| 2021-12-31 | $101,771,385 | 5,941,120 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||